AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
companies in this sector in UNITED STATES :
Eli Lilly and Company
sales of $22.32 billion
of which 100%
was Human Pharmaceuticals products),
Takeda Pharmaceutical Company Limited
of which 97%
was Pharmaceutical Business), and
Bristol-Myers Squibb Company
of which 30%
was Prioritized Brands-Eliquis).
During the year ended December of 2019, sales at
AstraZeneca PLC were $24.38 billion.
increase of 10.4%
versus 2018, when the company's sales were $22.09 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, AstraZeneca PLC had sales
of $26.10 billion.